Abstract
Previous meta–analyses of percutaneous coronary intervention (PCI) with drug–eluting stent (DES) versus coronary artery bypass grafting (CABG) for unprotected left main coronary artery disease (ULMCAD) have abstracted (and then combined) unadjusted risk estimates from not only a few randomized
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have